Company Profile for Goodwin Biotechnology Inc.

GBI is one of the earliest biopharmaceutical contract manufacturing organizations (CMOs), established in 1992. GBI specializes in process development and cGMP compliant mammalian cell culture manufacturing of bio-therapeutics for pre-clinical studies through Phase III clinical trials. The company and its predecessor, The Goodwin Institute for Cancer Research, have been operating in the biologics CMO sector since the early 1980's. GBI's clients include small to midsized biotech companies throughout North America and Europe, universities, renowned cancer research institutes and various branches of the U.S. government. GBI was acquired in 2004 by Wallace Pharmaceuticals Pvt. Ltd., a multi-specialty pharmaceutical manufacturer and distributor based in Goa, India. GBI and Wallace together offer clients the experience of an established US Contract Manufacturing Organization together with the potential for timeline and cost-effective scale up manufacturing in India.

Company:                 Goodwin Biotechnology Inc.
Headquarters Address:    1850 NW 69th Ave.
                         Plantation, FL 33313
Main Telephone:          954-321-5300
Website:                 www.goodwinbio.com
Type of Organization:    Private
Industry:                Other
Key Executives:          CEO: Stephanie Finnegan
                         Chairman: Karl Pinto
Executive VP for
Client Operations:
  Contact:               David Fischer
  Phone:                 954-327-9613
  Email:                 dfischer@goodwinbio.com